Site Members can sign up for company wide alerts
Lawsuit Overview
December 5, 2014 (Shareholders Foundation) - An investor, who currently holds shares of Avanir Pharmaceuticals Inc (NASDAQ:AVNR filed a lawsuit in effort to halt the proposed takeover of Avanir Pharmaceuticals Inc by Otsuka Pharmaceutical Co for $17.00 per share. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:AVNR stockholders by agreeing to ...
You must register (for free) or login to view the entire case.